{"schema_version":"secwatch.filing_event.v1","accession":"0000882095-26-000008","form_type":"8-K","ticker":"GILD","cik":"0000882095","company_name":"GILEAD SCIENCES, INC.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.858871+00:00","generated_at":"2026-05-15T00:10:55.630983+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Gilead shareholders elect all nine directors, approve equity plan increase, reject three proposals","bullets":["All nine director nominees elected; Daniel O'Day received 980.6M votes for, 50.2M against.","Ernst & Young ratified as auditor for FY 2026: 1,046.4M for, 82.8M against, 1.0M abstain.","Say-on-pay approved with 954.3M for (92.6% of votes cast excluding broker non-votes).","Amended 2022 Equity Incentive Plan approved, adding 47.75M new shares to the pool.","Shareholder proposals on independent chair, patent exclusivity, and ESG metrics all defeated by wide margins."],"urls":{"canonical":"https://secwatch.observer/filing/0000882095-26-000008","json":"https://secwatch.observer/filing/0000882095-26-000008.json","markdown":"https://secwatch.observer/filing/0000882095-26-000008.md","text":"https://secwatch.observer/filing/0000882095-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/0000882095-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/gild-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:10:55.630983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}